Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis

Therapie. 2023 May-Jun;78(3):328-330. doi: 10.1016/j.therap.2022.05.006. Epub 2022 May 21.

¹ Service de médecine interne, hôpital Cochin, AP-HP centre - université Paris Cité, 75014 Paris, France.
² Centre régional de pharmacovigilance, service de pharmacologie, hôpital Cochin, AP-HP centre - université Paris Cité, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France.
³ Centre régional de pharmacovigilance, CHU Rouen, 76031 Rouen, France.
⁴ Centre régional de pharmacovigilance, service de pharmacologie clinique et médicale, CHU Toulouse, 31000 Toulouse, France.
⁵ Centre régional de pharmacovigilance, service de pharmacologie, hôpital Cochin, AP-HP centre - université Paris Cité, 27, rue du Faubourg Saint-Jacques, 75014 Paris, France. Electronic address: [email protected].

No abstract available

Keywords: Adverse drug reaction; COVID-19 vaccine; Cross-reactivity; Immune thrombocytopenia; Pharmacovigilance.

Publication types